GRI Bio, Inc.
Calidad de datos: 83%
GRI
Nasdaq
Manufacturing
Chemicals
$2.45
▲
$0.09
(3.81%)
Cap. Mercado: 3.41 M
Precio
$2.36
Cap. Mercado
3.41 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—
Quick Summary
Puntos Clave
Negative free cash flow of -10.19 M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-449.90%
Below sector avg (-53.34%)
ROIC-351.15%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current Ratio1.70
Interest CoverageN/A
Valoración
PE (TTM)
-0.29
Above sector avg (-1.47)
P/B Ratio1.71
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -0.3 | -1.5 |
| P/B | 1.7 | 1.6 |
| ROE % | -449.9 | -53.3 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
Precio Objetivo de Analistas
2 analistas
Buy
Actual
$2.45
Objetivo
$160.00
$40.00
$160.00
$280.00
Pronóstico
P/E Futuro
-0.31
EPS Futuro
-$8.03
Ingresos Est.
0.0
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
-$8.03
-$10.64 – -$5.41
|
0.0 | 2 |
| FY2026 |
-$15.37
-$24.64 – -$6.10
|
0.0 | 2 |
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| 2026 Q2 |
-$3.72
-$5.88 – -$1.55
|
0.0 | 2 |
| 2026 Q1 |
-$3.74
-$5.88 – -$1.60
|
0.0 | 2 |
Sorpresas de Ganancias
Últimos 4 trimestres
| Trimestre | EPS Est. | EPS Real | Sorpresa |
|---|---|---|---|
| Q42025 | -$29.26 | -$116.61 | -298.5% |
| Q32025 | -$31.08 | -$35.84 | -15.3% |
| Q22025 | -$36.68 | -$36.68 | 0.0% |
| Q12025 | -$105.98 | -$162.40 | -53.2% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -11.96 M |
| ROE | -449.90% | ROA | -228.67% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -10.19 M |
| ROIC | -351.15% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.70 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 1.94 M | Tangible Book Value | 1.99 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.29 | Forward P/E | N/A |
| P/B Ratio | 1.71 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -298.77% | ||
| Market Cap | 3.41 M | Enterprise Value | -644,732.0 |
| Per Share | |||
| EPS (Diluted TTM) | -121.80 | Revenue / Share | N/A |
| FCF / Share | -7.05 | OCF / Share | -7.05 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 85.22% |
| SBC-Adj. FCF | -10.95 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 0.0 |
| Net Income | -11.96 M | -8.21 M | -13.04 M | -7.02 M | -9.30 M |
| EPS (Diluted) | -121.80 | -55.21 | -28.25 | -0.69 | -1.42 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -11.98 M | -8.24 M | -11.39 M | -6.93 M | -9.26 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 6.82 M | 3.77 M | 3.23 M | 1.17 M | 5.19 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 3,000.0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8.67 M | 5.74 M | 2.96 M | 4.15 M | 8.34 M |
| Total Liabilities | 2.66 M | 1.71 M | 2.70 M | 1.81 M | 2.52 M |
| Shareholders' Equity | 6.01 M | 4.03 M | 259,000.0 | 2.34 M | 5.82 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 8.23 M | 5.03 M | 1.81 M | 3.78 M | 3.70 M |
| Current Assets | 8.59 M | 5.62 M | 2.93 M | 4.15 M | 8.13 M |
| Current Liabilities | 2.64 M | 1.64 M | 2.70 M | 1.81 M | 2.45 M |
{"event":"ticker_viewed","properties":{"ticker":"GRI","listing_kind":"stock","pathname":"/stocks/gri","exchange":"Nasdaq","country":"US"}}